Trials / Completed
CompletedNCT04394481
Extension of Analgesia by Combined Injection of Dexamethasone and Dexmedetomidine After Arthroscopic Shoulder Surgery
Extension of the Analgesia of an Interscalene Block of the Brachial Plexus by Combined Injection of Dexamethasone and Dexmedetomidine, After Arthroscopic Shoulder Surgery: Randomized, Controlled, Double-blind Trial
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- GCS Ramsay Santé pour l'Enseignement et la Recherche · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of the study is to demonstrate the efficacy of Dexmedetomidine on the prolongation of analgesia obtained by interscalenic bloc of the brachial plexus and intravenous injection of Dexamethasone (efficacy objective).
Detailed description
This is an interventional, comparative, randomized, controlled study versus reference treatment, in 2 parallel groups, double blind (patient and evaluator), multicenter, aiming to demonstrate the superiority of This is an interventional, comparative, randomized, controlled study versus reference treatment, in 2 parallel groups, double blind (patient and evaluator), multicenter, aiming to demonstrate the superiority of Dexmedetomidine over the absence of Dexmedetomidine, in adjuvantation of a loco regional anesthesia (interscalenic bloc of the brachial plexus + intravenous injection of Dexamethasone), on the prolongation of the analgesia, following a surgery of the rotator cuff of the shoulder under arthroscopy. Patients will be randomized into 2 groups according to the treatment received: * Dexmedetomidine; * Nothing (control arm). The investigator (anesthesiologist) who will perform the randomization will not be blinded to the treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Dexmedetomidine | IV injection (1 µg/kg - 100 mL) before anesthetic induction |
| DRUG | Ropivacaine | Perinervous injection between C5 and C6 nerve roots / interscalene block (0.75% - 20 mL) |
| DRUG | Dexamethasone | IV injection (0.15 mg/kg) during anesthetic induction |
Timeline
- Start date
- 2020-09-28
- Primary completion
- 2021-12-11
- Completion
- 2021-12-11
- First posted
- 2020-05-19
- Last updated
- 2022-01-04
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT04394481. Inclusion in this directory is not an endorsement.